This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Livzon Pharmaceutical Group Co., Ltd. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Hongdan Chen in Pharmaceutical Composition
Introduction
Hongdan Chen is a notable inventor based in Zhuhai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address critical health issues. His work focuses on innovative solutions for treating gastrointestinal conditions.
Latest Patents
Hongdan Chen holds a patent for a pharmaceutical composition containing ilaprazole or a salt thereof, along with a preparation method for this composition. The invention is designed to treat peptic ulcer bleeding and stress ulcers, while also preventing upper gastrointestinal hemorrhage caused by severe diseases. The composition includes ilaprazole or its derivatives, with the amount of the derivative not exceeding 1.3 wt %.
Career Highlights
Chen is associated with Livzon Pharmaceutical Group Co., Ltd., where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing treatments that improve patient outcomes in gastrointestinal health.
Collaborations
Hongdan Chen collaborates with talented professionals in his field, including colleagues Tao Wang and Xuemei Hou. Their combined efforts contribute to the innovative research and development at Livzon Pharmaceutical Group.
Conclusion
Hongdan Chen's contributions to pharmaceutical innovations highlight the importance of research in developing effective treatments for serious health conditions. His work continues to impact the medical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile